Focus on vascular pharmacology.

Area of Science:

• Pharmacology
• Vascular Biology
• Toxicology

Background:

• The meeting focused on vascular pharmacology, addressing key areas like signaling pathways in vascular muscle and the endothelium-derived hyperpolarizing factor.
• Discussions covered molecular mechanisms of vascular contractility, ion channels, and smooth muscle cell growth.
• Keynote lectures addressed endothelial dysfunction and the pharmacology of hypertension.

Purpose of the Study:

• To review recent advancements in vascular pharmacology.
• To discuss the role of signaling pathways and endothelium-derived hyperpolarizing factor in vascular function.
• To explore the potential of genetic markers in predicting antihypertensive drug response.

Main Methods:

• Symposia and communications presented research findings.
• Discussions involved evaluating various candidates for endothelium-derived hyperpolarizing factor.
• Expert lectures provided overviews of endothelial dysfunction and hypertension pharmacology.

Main Results:

• G-protein-coupled receptors, lipid messengers, cyclic nucleotides, and Ca(2+) channels were discussed in vascular muscle signaling.
• The identity of endothelium-derived hyperpolarizing factor (EDHF) remained under discussion, with epoxyeicosatrienoic acids, K(+), C-type natriuretic peptide, hydrogen peroxide, and gap junctions considered.
• Endothelial dysfunction and hypertension were key topics, with potential links to genetic factors explored.

Conclusions:

• Vascular pharmacology is a dynamic field with ongoing research into signaling mechanisms and vascular regulation.
• The precise nature of endothelium-derived hyperpolarizing factor requires further investigation.
• Personalized medicine approaches, including DNA microsequencing for predicting drug response, show promise in hypertension management.